Asia Pacific trial sector poised for continued growth, says Novotech

By Gareth Macdonald

- Last updated on GMT

Related tags Asia pacific Contract research organization United states

Asia Pacific trial sector poised for continued growth, says Novotech
The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients, cut costs and improve data quality according to Novotech CEO Alek Safarian.

Safarian told Outsourcing-pharma there had been a four-fold increase in trials being conducted by contract research organisations (CRO) in a number of countries in Asia Pacific, with India, Taiwan and Novotech’s base, Australia, seeing the biggest gains.

He also predicted that, while in common with other developing clinical trial hubs like Latin America and Central and Eastern Europe (CEE) the Asia Pacific market will continue to expand, the three billion potential patients in the region make it a unique opportunity for sponsors.

Safarian also suggested that factors like Asia Pacific's ethnic diversity and its reverse seasonality, with respect to the Northern hemisphere, are becoming increasingly attractive to global pharmaceutical firms keen to tap emerging pharmaceutical markets.

Related news

Related products

show more

How a Clinical MDR Helps with Data Quality

How a Clinical MDR Helps with Data Quality

Formedix | 16-Jan-2023 | Technical / White Paper

This article covers the many ways a clinical metadata repository helps with data quality in the clinical trial process, and how it ultimately helps to...

Optimizing Adherence in DCTs

Optimizing Adherence in DCTs

PPD - Decentralized Clinical Trials | 12-Jan-2023 | Technical / White Paper

Prioritizing greater patient-centricity and creating an opportunity to reach unprecedented patient groups, decentralized and hybrid clinical trials are...

PPD is Supporting Complex EU DCTs

PPD is Supporting Complex EU DCTs

PPD - Decentralized Clinical Trials | 05-Jan-2023 | Technical / White Paper

PPD supports European DCTs and clinical trial sponsors with a holistic and comprehensive approach

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 14-Dec-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us

Products

View more

Webinars